Teleflex Incorporated (NYSE:TFX) Shares Sold by Fifth Third Bancorp

Fifth Third Bancorp reduced its stake in Teleflex Incorporated (NYSE:TFX) by 11.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,849 shares of the medical technology company’s stock after selling 511 shares during the period. Fifth Third Bancorp’s holdings in Teleflex were worth $685,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in TFX. Public Sector Pension Investment Board grew its position in Teleflex by 80.4% during the second quarter. Public Sector Pension Investment Board now owns 1,799 shares of the medical technology company’s stock valued at $378,000 after purchasing an additional 802 shares in the last quarter. AQR Capital Management LLC raised its holdings in Teleflex by 48.0% in the 2nd quarter. AQR Capital Management LLC now owns 59,707 shares of the medical technology company’s stock worth $12,356,000 after acquiring an additional 19,371 shares during the period. MBB Public Markets I LLC acquired a new position in shares of Teleflex during the 2nd quarter worth about $700,000. Mackenzie Financial Corp lifted its holdings in shares of Teleflex by 61.2% during the second quarter. Mackenzie Financial Corp now owns 20,934 shares of the medical technology company’s stock worth $4,403,000 after buying an additional 7,947 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its position in Teleflex by 19.8% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company’s stock worth $102,000 after acquiring an additional 80 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Down 0.3 %

Shares of Teleflex stock opened at $180.61 on Thursday. The stock has a market capitalization of $8.39 billion, a P/E ratio of 35.91, a price-to-earnings-growth ratio of 1.79 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $171.69 and a 12-month high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a 50-day simple moving average of $182.40 and a 200 day simple moving average of $213.73.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.64 earnings per share. Research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho cut their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Truist Financial decreased their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Royal Bank of Canada lowered their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Teleflex currently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.